SCHEDULE: Vanguard Group Updates Passive Stake in InfuSystem Holdings

The Vanguard Group has filed an amended Schedule 13G, reporting a 4.56% passive ownership stake in InfuSystem Holdings Inc. as of June 30, 2025.

Summary

• The Vanguard Group reported beneficial ownership of 957,638 shares of InfuSystem Holdings Inc. Common Stock.
• This represents 4.56% of the class of securities.
• The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previously reported stake.
• Vanguard holds sole dispositive power over 949,762 shares and shared dispositive power over 7,876 shares.
• Vanguard holds no sole or shared voting power over these shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The filing is a routine beneficial ownership disclosure by a passive institutional investor, providing no direct positive or negative operational or financial news about the issuer. The slight reduction in stake below 5% is a neutral event for most investors.

Positives

• The continued presence of a major institutional investor like The Vanguard Group, even with a reduced stake, can signal ongoing institutional interest in InfuSystem Holdings Inc.

Negatives

• The reported ownership percentage of 4.56% is below the 5% threshold, suggesting a reduction in Vanguard's stake from a previous filing, which could be interpreted as a slight decrease in institutional conviction, though it is a routine disclosure.

Future Outlook

The filing does not provide any forward-looking statements or guidance from InfuSystem Holdings Inc. or The Vanguard Group regarding the company's future performance or strategic direction, beyond Vanguard's certification that its holdings are for passive investment purposes.

Management Comments

• The Vanguard Group certified that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

This filing is a routine disclosure of beneficial ownership by a large asset manager and does not provide specific insights into broader industry trends or competitive dynamics within the healthcare or medical device sector where InfuSystem Holdings Inc. operates. It reflects a portfolio adjustment by a passive investor.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's updated stake, indicating a passive investment approach.

Key Dates

Keywords

InfuSystem Holdings Inc, Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Passive Investment